Anti-Mouse Fas Ligand Antibody (MFL3)
Anti-Mouse Fas Ligand Antibody (MFL3) is an anti-mouse Fas Ligand IgG antibody inhibitor derived from host Armenian Hamster. Anti-Mouse Fas Ligand Antibody (MFL3) can block Fas Ligand (FasL). Anti-Mouse Fas Ligand Antibody (MFL3) can be used for the researches of cancer and immunology.
For research use only. We do not sell to patients.
- Molecular Weight:150 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Armenian Hamster IgG
Recommend Isotype Controls
Species Reactivity
Mouse
IC50 & Target
Fas Ligand
In Vivo
Anti-Mouse Fas Ligand Antibody (MFL3) (10-200 μg, i.p., a single dose) prolongs survival in Cisplatin (HY-17394)-induced acute kidney failure mice[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Mice bearing 3e6 heterogeneous tumor[1]
-
Dosage:500 μg for the first time and 250 μg every 3 days from the day of adoptive T cell transfer
-
Administration:Intraperitoneally injection
-
Result:Impaired CAR-T efficacy.
Reduced survival of mice.
-
Animal Model:Cisplatin (HY-17394)-induced acute kidney failure C57/B6N mice[1]
-
Dosage:10, 50 and 200 μg
-
Administration:Intraperitoneally injection
-
Result:Reduced serum urea and serum creatinine.
Reduced the renal damage score and apoptotic cells.
Prolonged survival of mice.
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Product Image
Application
in vivo FasL blockade; In vitro FasL blockade; Functional assay; Immunohistochemistry (paraffin);
Chemical Information
-
Molecular Weight 150 kDa
-
SMILES
[Anti-Mouse Fas Ligand Antibody (MFL3)]
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Upadhyay R, et al. A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy. Cancer Discov. 2021 Mar;11(3):599-613. [Content Brief]
[2]. Linkermann A, et al. Renal tubular Fas ligand mediates fratricide in cisplatin-induced acute kidney failure. Kidney Int. 2011 Jan;79(2):169-78. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)